Diabetes mellitus is an epidemic in the United States that disproportionately affects racial/ethnic minorities, with higher prevalence in black, Hispanic, and Asian populations than in the white population.1 Racial/ethnic minorities with diabetes also have worse outcomes, including higher risks of…
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
Read the current issue. Keep up to date with the latest research, clinical reviews, and opinions.
In the first publication on continuous intracranial pressure (ICP) monitoring in patients with traumatic brain injury (TBI) in 1965, Lundberg et al1 described periodic increases…
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
This cohort study examines rates of positive tests, hospitalizations, and deaths for COVID-19 and influenza across the influenza seasons of 2022 to 2023, 2023 to…
This prognostic study describes the development and validation of survival models using electronic health record data to predict the time to progression to proliferative diabetic…
This cross-sectional study used data from the COVID-19 Hospitalization Surveillance Network to characterize trends in pediatric COVID-19 hospitalizations by race and ethnicity from March 2020…
